Literature DB >> 24589580

A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation.

Youyong Yuan1, Yilong Chen, Ben Zhong Tang, Bin Liu.   

Abstract

A targeted theranostic platinum(IV) prodrug based on a luminogen with aggregation-induced emission (AIE) characteristics was developed for selective and real-time monitoring of drug activation in situ.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24589580     DOI： 10.1039/c3cc49516g

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  9 in total

1.  A Carrier-Free Nanostructure Based on Platinum(IV) Prodrug Enhances Cellular Uptake and Cytotoxicity.

Authors:  Jingjie Tan; Chan Li; Qian Wang; Shuyi Li; Shizhu Chen; Jinchao Zhang; Paul C Wang; Lei Ren; Xing-Jie Liang
Journal:  Mol Pharm       Date:  2018-03-14       Impact factor: 4.939

Review 2.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

3.  Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug release.

Authors:  Jinfeng Zhang; Shengliang Li; Fei-Fei An; Juan Liu; Shubin Jin; Jin-Chao Zhang; Paul C Wang; Xiaohong Zhang; Chun-Sing Lee; Xing-Jie Liang
Journal:  Nanoscale       Date:  2015-07-22       Impact factor: 7.790

Review 4.  Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics.

Authors:  Min Hee Lee; Amit Sharma; Min Jung Chang; Jinju Lee; Subin Son; Jonathan L Sessler; Chulhun Kang; Jong Seung Kim
Journal:  Chem Soc Rev       Date:  2018-01-02       Impact factor: 54.564

5.  Visualization of drug delivery processes using AIEgens.

Authors:  Youyong Yuan; Bin Liu
Journal:  Chem Sci       Date:  2017-01-18       Impact factor: 9.825

Review 6.  Theranostics based on AIEgens.

Authors:  Dong Wang; Michelle Mei Suet Lee; Wenhan Xu; Ryan Tsz Kin Kwok; Jacky Wing Yip Lam; Ben Zhong Tang
Journal:  Theranostics       Date:  2018-09-09       Impact factor: 11.556

7.  Gd(iii)-Pt(iv) theranostic contrast agents for tandem MR imaging and chemotherapy.

Authors:  Casey J Adams; Thomas J Meade
Journal:  Chem Sci       Date:  2020-01-28       Impact factor: 9.825

Review 8.  Peptide-drug conjugates as effective prodrug strategies for targeted delivery.

Authors:  Yin Wang; Andrew G Cheetham; Garren Angacian; Hao Su; Lisi Xie; Honggang Cui
Journal:  Adv Drug Deliv Rev       Date:  2016-06-29       Impact factor: 15.470

Review 9.  Metallodrugs are unique: opportunities and challenges of discovery and development.

Authors:  Elizabeth J Anthony; Elizabeth M Bolitho; Hannah E Bridgewater; Oliver W L Carter; Jane M Donnelly; Cinzia Imberti; Edward C Lant; Frederik Lermyte; Russell J Needham; Marta Palau; Peter J Sadler; Huayun Shi; Fang-Xin Wang; Wen-Ying Zhang; Zijin Zhang
Journal:  Chem Sci       Date:  2020-11-12       Impact factor: 9.825
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.